Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Lorin

Clarisse Marie-Madeleine Lorin, Rixensart BE

Patent application numberDescriptionPublished
20110236468VACCINE COMPOSITIONS - The present invention relates, inter alia, to a method of raising an immune response against a pathogen which comprises administering (i) one or more first immunogenic polypeptides derived from said pathogen; (ii) one or more viral vectors comprising one or more heterologous polynucleotides encoding one or more second immunogenic polypeptides derived from said pathogen; and (iii) an adjuvant; wherein the one or more first immunogenic polypeptides, the one or more viral vectors and the adjuvant are administered concomitantly. The invention also relates to vaccines, pharmaceutical compositions, kits and uses employing said polypeptides, viral vectors and adjuvants.09-29-2011

Hervé Lorin, Poitiers FR

Patent application numberDescriptionPublished
20100079021Housing Comprising An Air Flow Conduit Preventing All Liquid Accumulation - A liquid tightly sealed housing has an electrical or electronic device arranged in an internal volume of the housing, a channel with a globally vertical main axis, passing through an upper wall of the housing to connect the internal volume of the housing to outside, and closure apparatuses for making the channel liquid-tight and gas-permeable. The closure apparatuses are arranged at least partly on the upper wall of the housing and at an upper end of the channel so as to prevent any liquid accumulation in the channel.04-01-2010

Hervé Lorin, Poitiers FR

Patent application numberDescriptionPublished
20100079021Housing Comprising An Air Flow Conduit Preventing All Liquid Accumulation - A liquid tightly sealed housing has an electrical or electronic device arranged in an internal volume of the housing, a channel with a globally vertical main axis, passing through an upper wall of the housing to connect the internal volume of the housing to outside, and closure apparatuses for making the channel liquid-tight and gas-permeable. The closure apparatuses are arranged at least partly on the upper wall of the housing and at an upper end of the channel so as to prevent any liquid accumulation in the channel.04-01-2010

Valerie Lorin, Paris FR

Patent application numberDescriptionPublished
20120045469VACCINE - The present invention provides an immunogenic composition comprising: an immunogenic SARS coronavirus S (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising an oil-in-water emulsion.02-23-2012

Valerie Lorin, Nontrouge FR

Patent application numberDescriptionPublished
20100233250VACCINE - The present invention provides a vaccine or immunogenic composition comprising: an immunogenic SARS coronavirus S (spike) polypeptide, or a fragment or variant thereof; and an adjuvant comprising a lipopolysaccharide, a saponin and a liposome.09-16-2010

Valérie Lorin, Montrouge FR

Patent application numberDescriptionPublished
20110065089NOVEL STRAIN OF SARS-ASSOCIATED CORONAVIRUS AND APPLICATIONS THEREOF - The invention relates to a novel strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from a sample collected in Hanoi (Vietnam), reference number 031589, nucleic acid molecules originating from the genome of same, proteins and peptides coded by said nucleic acid molecules and, more specifically, protein N and the applications thereof, for example, as diagnostic reagents and/or as a vaccine.03-17-2011

Valérie Lorin, Montrouge FR

Patent application numberDescriptionPublished
20110065089NOVEL STRAIN OF SARS-ASSOCIATED CORONAVIRUS AND APPLICATIONS THEREOF - The invention relates to a novel strain of severe acute respiratory syndrome (SARS)-associated coronavirus, resulting from a sample collected in Hanoi (Vietnam), reference number 031589, nucleic acid molecules originating from the genome of same, proteins and peptides coded by said nucleic acid molecules and, more specifically, protein N and the applications thereof, for example, as diagnostic reagents and/or as a vaccine.03-17-2011